Discover

CLRB
Cellectar Biosciences, Inc.
2.64
3 x 2.31
5 x 2.65
bid
ask
+
0.04
1.54%
1 @ 04:00 PM
2.64 +0.00 (0.00%)
Ytd-10.51%
1y-40.54%
2.55
day range
2.65
2.20
52 week range
6.52
Open2.55Prev Close2.60Low2.55High2.65Mkt Cap21.09M
Vol20.07KAvg Vol136.78KEPS-6.66P/E-0.40Forward P/E-0.10
Beta1.01Short Ratio8.34Inst. Own34.55%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg2.58200-d Avg3.021yr Est5.67

CLRB News

Analysts Set Cellectar Biosciences, Inc. (NASDAQ:CLRB) PT at $11.00
defenseworld.net
Analysts Set Cellectar Biosciences, Inc. (NASDAQ:CLRB) PT at $11.00

Cellectar Biosciences, Inc. (NASDAQ: CLRB - Get Free Report) has been given an average rating of "Mo

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
globenewswire.com
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thurs

FLORHAM PARK, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a

benzinga.com
Cellectar Biosciences Announces Publication Of Results From Phase 1 Dose-Escalation Study Evaluating

Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in Relapsed/Refractory Multi

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
globenewswire.com
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Jo

Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in  Relapsed/Refractory Mult

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting
globenewswire.com
Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Io

Approximately 80% Major Response Rate and Duration of Response Exceeding 16 Months in Subset Analysi

Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript
seekingalpha.com
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Announced Positive 12-month Follow-on Data for Iopofosine I 131 in relapsed/refractory Waldenström M

Earnings Scheduled For May 14, 2026
benzinga.com
Earnings Scheduled For May 14, 2026

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
globenewswire.com
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursd

FLORHAM PARK, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a l

Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know
zacks.com
Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know

Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism

What's Going With Cellectar Biosciences Stock On Wednesday?
benzinga.com
What's Going With Cellectar Biosciences Stock On Wednesday?

Cellectar Biosciences Inc (NASDAQ:CLRB) shares are down during Wednesday's premarket session after t

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings
benzinga.com
Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 e

Cellectar Biosciences Stock Rallies As Blood Cancer Data Impresses
benzinga.com
Cellectar Biosciences Stock Rallies As Blood Cancer Data Impresses

Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares are up during Tuesday's trading session as the comp

Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
globenewswire.com
Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demons

83.6% ORR and 61.8% MRR achieved in heavily pretreated population with median duration of response o

Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million
globenewswire.com
Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million

Oversubscribed Financing Led by Nantahala Capital with Participation from Balyasny Asset Management,

Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
globenewswire.com
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Tar

Study will evaluate tumor-specific uptake, safety, tolerability, and preliminary efficacy signals of

Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript
seekingalpha.com
Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript

Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
globenewswire.com
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

On track to submit Conditional Marketing Authorization for iopofosine I 131 to European Medicines Ag

Earnings Scheduled For March 4, 2026
benzinga.com
Earnings Scheduled For March 4, 2026

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
globenewswire.com
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday,

FLORHAM PARK, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a

Cellectar Biosciences Expands Global Intellectual Property Estate
globenewswire.com
Cellectar Biosciences Expands Global Intellectual Property Estate

Strengthens Protection Around Broad Portfolio of Cancer-Targeting Drug Conjugates and Enabling Techn

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
globenewswire.com
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase durin

Following Guidance from the European Medicines Agency's (EMA) Scientific Advice Working Party (SAWP)

Earnings Scheduled For November 13, 2025
benzinga.com
Earnings Scheduled For November 13, 2025

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
Earnings Scheduled For August 14, 2025

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May
benzinga.com
Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May

benzinga.com
Earnings Scheduled For May 13, 2025

benzinga.com
Earnings Scheduled For March 13, 2025

benzinga.com
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket

benzinga.com
Earnings Scheduled For November 18, 2024

benzinga.com
Gold Moves Higher; Coca-Cola Increases FY24 Forecast

benzinga.com
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessio

benzinga.com
Crude Oil Down 2%; GE Aerospace Earnings Top Views

benzinga.com
Earnings Scheduled For March 27, 2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly los

benzinga.com
Earnings Scheduled For November 2, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

    During Tuesday's trading, 505 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

    On Friday morning, 155 companies achieved new lows for the year.

benzinga.com
Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thur., May 16, 2019

Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thur., May 16, 2019

benzinga.com
60 Biggest Movers From Yesterday

60 Biggest Movers From Yesterday

benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018

benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018

benzinga.com
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018

Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018